Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN4 SHORT NOTE 5M ★ High-yield

Differentiate zero-order from first-order kinetics with examples and clinical significance.

Pharmacology · 2nd Professional — Para-Clinical

Definitions

OrderDefinitionEquation
First-order kineticsThe rate of elimination is directly proportional to the plasma concentration; a constant fraction of the drug present is eliminated per unit timeRate = k × C
Zero-order (saturation, Michaelis–Menten) kineticsA constant amount of drug is eliminated per unit time, independent of the plasma concentration, because the eliminating enzymes or carriers are saturatedRate = k (a constant)

Comparison

FeatureFirst-orderZero-order
Enzyme saturationNot saturatedSaturated
Amount eliminated per unit timeVaries with concentrationConstant
Fraction eliminated per unit timeConstantVaries
Half-lifeConstant and meaningfulNot constant — rises with dose; the term does not properly apply
Semilogarithmic plotStraight lineCurved
Linear plotCurved (exponential decay)Straight line
ClearanceConstantFalls as concentration rises
Doubling the doseDoubles the steady-state concentration — predictableCauses a much greater than twofold rise — may precipitate toxicity
Time to steady state4 to 5 half-livesProlonged and unpredictable
Applies toThe great majority of drugs at therapeutic dosesPhenytoin, ethanol, aspirin in high dose, theophylline, tolbutamide, heparin, warfarin at high dose, dicoumarol

CLINICAL PEARL

Zero-order kinetics is dangerous because the margin between an effective and a toxic dose disappears. With phenytoin, an increase from 300 to 400 mg a day may raise the plasma level not by a third but three- or fourfold, tipping a controlled patient into nystagmus, ataxia and confusion. This is why phenytoin doses are increased in 25 to 50 mg increments once the level approaches the therapeutic range.

Drugs Showing a Change of Order

  • Some drugs follow first-order kinetics at therapeutic doses and switch to zero-order once the enzymes saturate — and it is exactly this transition that makes them hazardous
  • Aspirin — first-order at analgesic doses, zero-order at anti-inflammatory and toxic doses; hence the danger of salicylate poisoning
  • Phenytoin — saturation occurs within the therapeutic range itself
  • Ethanol is zero-order at almost all concentrations, eliminated at about 10–15 mL an hour whatever the amount consumed — which is why time is the only remedy for intoxication
  • Theophylline and tolbutamide at higher doses

Applied Aspects

  • Increase phenytoin in small increments and monitor levels — the single most important practical consequence of zero-order kinetics
  • In salicylate poisoning, elimination is slow and unpredictable, so levels must be repeated; urinary alkalinisation and, in severe cases, haemodialysis are used
  • There is no way to accelerate ethanol elimination — coffee, exercise and cold showers do nothing; only time works
  • Drug levels rise disproportionately in a saturated system, so a patient who has been stable for months may become toxic after a small dose increase or after starting an enzyme inhibitor
  • Steady state cannot be predicted from half-life in zero-order kinetics, so the usual rule of four to five half-lives does not apply

All questions in General Pharmacology: Pharmacokinetics

  1. Q1Classify the routes of drug administration. Describe their advantages and disadvantages. Add a note on the mechanisms of drug transport across membranes. ★
  2. Q2Define absorption and bioavailability. Describe the factors affecting them and add a note on first-pass metabolism. ★
  3. Q3Describe the distribution of drugs. Explain the volume of distribution, plasma protein binding and the barriers to distribution. ★
  4. Q4Define biotransformation. Describe phase I and phase II reactions and the factors modifying drug metabolism. ★
  5. Q5Describe the excretion of drugs. Explain clearance, half-life and the kinetics of elimination. Add a note on therapeutic drug monitoring. ★
  6. SN1Describe first-pass metabolism with its sites, consequences and clinical significance. ★
  7. SN2Define enzyme induction and inhibition. Compare them and describe their clinical consequences. ★
  8. SN3Define volume of distribution. Describe the factors affecting it and its clinical applications. ★
  9. SN4Differentiate zero-order from first-order kinetics with examples and clinical significance. ★
  10. SN5Define plasma half-life. Explain the plateau principle and the factors altering half-life. ★
  11. SN6Define prodrug. Give the reasons for using prodrugs with examples. ★
  12. SN7Classify drug interactions. Describe the pharmacokinetic and pharmacodynamic interactions with examples.

Every Pharmacology chapter →

Scroll to Top